What Eurosirel does

Eurosirel S.p.A. is an Italian Contract Development and Manufacturing Organization (CDMO) specializing in the private-label production of medical devices and cosmetics. Founded as Sirel® in 1975 by Leonelli and rebranded to its current name in 1990, the company operates a fully integrated, 100% Made-in-Italy supply chain from its single-site headquarters and production facility in Cusago, near Milan. Its portfolio spans two main families: Care products (wound dressings, post-operative plasters, scar and herpes treatment patches, FIR-based pain relief patches, nasal and aroma respiratory patches, and self-diagnostic/prevention items) and Beauty products (hydrogel face masks, eye contour patches, acne and blackhead patches, collagen masks, lip balms, depilatory strips, and hand/foot care). Underlying the range are three proprietary technology platforms — Far Infrared Ray (FIR), Advanced Hydrogel, and Advanced Dressings — supported by R&D investment of over 10% of turnover annually and a multidisciplinary internal R&D team working with international scientific partners.

Eurosirel generates revenue through two complementary streams. The core stream is private-label contract manufacturing for B2B clients, covering the full product lifecycle from concept and formulation through packaging design, industrial production, logistics, and post-sales support. The secondary stream is a proprietary portfolio sold under its own brand lines (Care and Beauty). Pricing is not publicly disclosed and is negotiated on a per-project basis against product specifications, volume, customization, and regulatory complexity. Distribution is exclusively indirect: products are sold through named channel partners including pharmacy chains (Bausch, since 2008; Sanofi in the pharmaceutical consumer healthcare space), major Italian retail groups (Despar, Coop, Marcadonna), and multinational care & beauty companies. Export operations span more than 60 countries, with US market entry completed in 2019 and broader global expansion following the 2023 ownership change.

The company's competitive posture relies on its scale (over 1.5 billion units produced annually), its unusually broad regulatory certification portfolio (ISO 13485, ISO 22716, IFS HPC, BRC, SA8000, RSPO, C-TPAT, GOTS, VeganCert, Eco Bio Cosmesi, and CE markings from IMQ, ISS, and TUV Sud), and a proprietary technology stack that supports differentiation in pain relief, anti-cellulite, anti-age face care, and wound care. Headcount is stated at 51–100 employees. The 2023 ownership transition brought a new strategic vision oriented toward higher added-value offerings and additional global markets. No public ticker, institutional investors, or M&A activity are disclosed in the input data.

Name

Eurosirel

Legal name

Eurosirel S.p.A.

Website

https://eurosirel.it

Company type

Private

Founded year

1975

Operating status

Operating

Headcount range

51–100 employees

Short description

Eurosirel is an Italian CDMO that designs, develops, and manufactures private-label medical devices and cosmetics from a 100% Made-in-Italy facility in Cusago (Milan), producing over 1.5 billion units per year for pharmacy chains (Bausch, Sanofi), large retailers (Despar, Coop, Marcadonna), and multinational care & beauty companies across 60+ countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Cusano Milanino

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Private Label Manufacturing (CDMO): Eurosirel designs and manufactures customized medical devices and cosmetics under client brands via a private-label model. Revenue is generated through long-term B2B contracts, with production spanning the full product lifecycle from concept to commercialization. The company manages the entire value chain internally including R&D, formulation, packaging, production, logistics, and post-sales support.
2. Proprietary Product Portfolio: Eurosirel also offers a comprehensive portfolio of health and beauty products under its own brand lines (Care and Beauty categories), including wound plasters, pain relief patches, nasal patches, diagnostic tests, face care patches, lip balms, depilatory strips, and foot care solutions.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels3 records

Core offering

Eurosirel is an Italian CDMO that designs, develops, formulates, and manufactures private-label medical devices and cosmetics for B2B clients. Its offering covers the full product lifecycle — concept, R&D, formulation, packaging design, industrial production, logistics, and post-sales support — delivered through an integrated, 100% Made-in-Italy supply chain with annual capacity exceeding 1.5 billion units and exports to 60+ countries.

Product overview

Eurosirel is a European CDMO (Contract Development and Manufacturing Organization) specializing in private label manufacturing of medical devices and cosmetics. The company offers a comprehensive portfolio organized into two main categories: Care Products (medical devices including medication/wound care, pain relief with FIR technology, respiratory/breathe products, and diagnostic/prevention items) and Beauty Products (cosmetic face care with hydrogel technology, lips care, body care, and hands/feet care). The core service is an end-to-end private label solution guiding clients from product concept through formulation, packaging design, industrial production, logistics, and post-sales support. Proprietary technologies include FIR (Far Infrared Ray), Advanced Hydrogel, and Advanced Dressings technologies. With over 50 years of experience, the company produces over 1.5 billion units annually and exports to over 60 countries through a 100% Made in Italy integrated supply chain.

Differentiator

Problem solved

Functional benefit

Brands

• Sirel®: Original brand founded by Leonelli in 1975, later rebranded to Eurosirel

Products and services

• Wound Care / Medication Products Medical device wound care products including wound plasters, post-surgery dressings, scar/herpes/suture treatment patches, and cloth rolls, bandages, and gauzes manufactured for B2B private-label clients in the pharmacy, retail, and multinational channels.
• Pain Relief Products Natural-ingredient pain relief patches, self-heating patches, and hot/cold therapy products that apply the company's proprietary Far Infrared Ray (FIR) technology for discomfort management. Produced for B2B private-label clients across pharmacy, retail, and care & beauty channels.
• Respiratory / Breathe Products Respiratory wellness products including aroma patches, nasal patches, and saline solutions for breathing support, manufactured for B2B private-label distribution.
• Diagnostic and Prevention Products Self-diagnostic medical devices and preventive health products including thermometers, self-diagnostic tests (such as pregnancy tests), syringes, condoms, urine containers, and mosquito repellent patches, manufactured for B2B private-label clients.
• Face Care Cosmetic Products Cosmetic facial care products including acne/pimple patches, blackhead patches, hydrogel masks, eye patches, collagen masks, eye pads, and toner pads, leveraging proprietary Advanced Hydrogel technology for controlled release of actives.
• Lip Care Products Lip care cosmetics including natural lipbalm, protective lipbalm, and face stick formulations, produced for B2B private-label distribution.
• Body Care Products Body cosmetics including cosmetic patches (including anti-cellulite patches using FIR technology) and depilatory strips, manufactured for B2B private-label clients.
• Hands and Feet Care Products Hand and foot care products for corns and calluses, blisters, warts, and feet wellness masks, produced for B2B private-label distribution.
• CDMO Private Label Manufacturing Service Contract Development and Manufacturing Organization (CDMO) service delivering custom private-label medical devices and cosmetics for pharmacy chains, retail groups, and multinational companies. The service covers the full product lifecycle: concept, R&D, formulation, packaging design, regulatory support, industrial production, logistics, and post-sales service.

Quantifiable outcome

• Over 1.5 billion units produced per year
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core.

• BauschcoreChannel Partner/ Reseller/ Distributor · 1 January 2008Bausch is a major pharmacy chain and the first pharmaceutical chain partner of Eurosirel, established in 2008. The partnership involves the distribution of private-label medical devices and cosmetics through Bausch's pharmacy network, marking a significant milestone in Eurosirel's channel development.
• DesparcoreChannel Partner/ Reseller/ DistributorDespar is a major European retail group operating supermarket and hypermarket chains across Italy and other countries. Despar distributes Eurosirel's private-label health and beauty products through its retail outlets, representing a core channel partnership for the consumer-facing distribution of Eurosirel's care and cosmetics product lines.
• SanoficoreChannel Partner/ Reseller/ DistributorSanofi is a global pharmaceutical multinational specializing in consumer healthcare, vaccines, and specialty care. Sanofi distributes Eurosirel-manufactured private-label products in the care & beauty sector, leveraging Eurosirel's manufacturing capabilities and regulatory expertise for product commercialization.
• MarcadonnacoreChannel Partner/ Reseller/ DistributorMarcadonna is a retail chain partner distributing Eurosirel's private-label care and beauty products through its outlets, representing an established channel partnership in the Italian market.
• CoopcoreChannel Partner/ Reseller/ DistributorCoop is one of Italy's largest retail cooperatives, operating supermarkets and hypermarkets. Coop distributes Eurosirel's private-label health and beauty products through its extensive retail network, making it a key channel partner for the mass-market distribution of Eurosirel's product portfolio.

Scale indicators7 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Fareva: French-headquartered CDMO group with plants across Europe producing pharmaceuticals, cosmetics, and household care products on a contract basis. Highly comparable business model and customer base to Eurosirel's private-label medical-device and cosmetics operation.
• Recipharm: Swedish-headquartered pharmaceutical CDMO offering development and manufacturing services to pharma and consumer-health companies. Comparable as a European contract manufacturer serving regulated personal care and healthcare customers with multi-country operations.
• Intercos S.p.A. Italian-listed CDMO specializing in color cosmetics and skin-care formulation and manufacturing for global brands. Directly comparable to Eurosirel as a European-based contract manufacturer serving multinational brand owners with end-to-end formulation-to-production services.
• Bormioli Pharma: Italian-headquartered primary packaging and CDMO supplier to the pharmaceutical industry. Peer given its Italian base, regulated pharmaceutical customer base, and integrated supply chain serving drug and consumer-health customers — adjacent but overlapping with Eurosirel's medical-device CDMO positioning.
• Aenova Group: German pharmaceutical and consumer-health CDMO operating multiple European manufacturing sites for solid dosage forms and related products. Relevant comparable as a mid-sized European private CDMO serving regulated healthcare customers.
• Siegfried Holding: Swiss-listed pharmaceutical CDMO with manufacturing sites in Europe, the US and Asia supplying global pharma customers. Comparable as a regulated, multi-jurisdiction contract manufacturer with similar customer profiles in consumer healthcare.

Regional players

• Artsana Group: Italian family-owned group (parent of Chicco, Pic Solution, Lycia) developing and manufacturing personal-care, healthcare, and baby products for European and global retail. Comparable given its Italian base and integrated development-to-manufacturing model in the same product categories.

Broad incumbents

• ACRAF (Angelini Industries): Italian privately-held industrial group with consumer-health, personal-care, and pharmaceutical manufacturing operations. Comparable as an Italian-based manufacturer overlapping with Eurosirel's categories, though much broader across pharma and consumer products.
• Catalent: Large US-listed global CDMO with broad capabilities across biologics, softgel, oral, and consumer health. Comparable as a CDMO serving multinational consumer-health and pharma customers, though substantially larger and broader in scope than Eurosirel.

Emerging players

• Dermopharma: Smaller Italian contract manufacturer focused on cosmetics and personal-care products for brand owners. Comparable as a similarly positioned Italian CDMO serving cosmetics customers with private-label services, though at a smaller scale than Eurosirel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/eurosirel-spa

Compliance16 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eurosirel